Results 81 to 90 of about 5,272 (205)

Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma?

open access: yes, 2011
We measured plasma human herpesvirus 8 (HHV8) DNA load in consecutive patients presenting with HIV-associated multicentric Castleman disease (MCD) and in contemporaneous patients who had Kaposi sarcoma (KS), lymphoma or other diagnoses.
J Paul   +8 more
core   +1 more source

Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir

open access: yesAIDS Research and Therapy, 2019
Background Human herpes virus 8 (HHV8) is the causative agent of Kaposi’s sarcoma and has been associated with an increasing number of hematologic diseases such as primary effusion lymphoma (PEL) (both classic and extracavitary form), multicentric ...
Laura Campogiani   +9 more
doaj   +1 more source

Comparison of Prevalence of Kaposi's Sarcoma in HHV8+ and HHV8- HIV Infected Patients in South-South Nigeria

open access: yesGlobal Journal of Health Science, 2011
This study was carried out to see if there are any differences between the prevalence of Kaposi’s sarcoma in HIV infected patients with antibody to Human Herpes Virus 8 (HHV8) or not. Methods: The sera of 180 subjects were evaluated for HIV and HHV8 using double ELISA (Genscreen Ultra HIV Ag-Ab ELISA and JN HIV 1/2 ELISA Kit) for HIV screening and ...
Bob Agwu Ukonu   +2 more
openaire   +2 more sources

TAFRO syndrome: current perspectives

open access: yesJournal of Blood Medicine, 2018
Kentaro Sakashita,1,2 Kengo Murata,2 Mikio Takamori2 1Department of Internal Medicine, Tokyo Metropolitan Matsuzawa Hospital, 2Department of Respiratory Medicine, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan Abstract: Multicentric Castleman’
Sakashita K, Murata K, Takamori M
doaj  

Crude association between HHV8 seropositivity and socioeconomic and environmental variables among sexually active adults in Uganda.

open access: yes, 2013
aWeighted frequency of HHV8 seropositivity.bP for heterogeneity unless otherwise is indicated.
Stella S. Munuo (349442)   +9 more
core   +1 more source

Patient Demographics, HHV8 DNA and Antibody Positivity, and clinical Details for participants with non-KS malignancies.

open access: yes, 2018
Patient Demographics, HHV8 DNA and Antibody Positivity, and clinical Details for participants with non-KS malignancies.
Christine D. Palmer (257323)   +11 more
core   +1 more source

Patient Demographics, HHV8 DNA and Antibody Positivity, and clinical Details for participants with biopsy proven KS.

open access: yes, 2018
Patient Demographics, HHV8 DNA and Antibody Positivity, and clinical Details for participants with biopsy proven KS.
Christine D. Palmer (257323)   +11 more
core   +1 more source

Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up

open access: yesCase Reports in Hepatology, 2018
A 59-year-old male with a history of hepatitis C cirrhosis and history of hepatitis B exposure presented 8 months after orthotopic liver transplant (LT) with fever, fatigue, myalgia, night sweats, nonproductive cough, and shortness of breath. Bone marrow
Lokesh K. Jha   +5 more
doaj   +1 more source

Association between KSHV-Specific Humoral and T Cell Responses with Recurrence of HIV-Associated Kaposi Sarcoma

open access: yesTropical Medicine and Infectious Disease
Kaposi sarcoma (KS) is an AIDS-defining angio-proliferative malignancy, with the Kaposi sarcoma-associated herpes virus (KSHV) as its etiologic agent.
Marie-Claire Mukasine   +6 more
doaj   +1 more source

Crude association between HHV8 seropositivity and demographical and sexual variables among sexually active adults in Uganda.

open access: yes, 2013
aWeighted frequency of HHV8 seropositivity.bP for heterogeneity unless otherwise is indicated.cBased on questionnaire data.
Stella S. Munuo (349442)   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy